Literature DB >> 15193583

Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies.

Atsuko Nagano-Saito1, Takashi Kato, Yutaka Arahata, Yukihiko Washimi, Akinori Nakamura, Yuji Abe, Takako Yamada, Katsushige Iwai, Kentaro Hatano, Yasuhiro Kawasumi, Teruhiko Kachi, Alain Dagher, Kengo Ito.   

Abstract

OBJECTIVE: Using 6-[(18)F]fluoro-L-dopa (FDOPA) and [(18)F]fluorodeoxyglucoce (FDG) positron emission tomography (PET), multiple regression analyses were performed to determine the specific brain regions that are related to cognitive and motor symptoms in nondemented patients with Parkinson's disease.
METHODS: Spatially normalized images of FDOPA influx rate constant (Ki) values and relative regional cerebral metabolic rates for glucose (rrCMRglc) were created. Raven's Coloured Progressive Matrices (RCPM) scores and the Unified Parkinson's Disease Rating Scale (UPDRS) motor scores were used to determine the patients' cognitive and motor functions, respectively. Multiple correlation analyses between the FDOPA and FDG images and the cognitive and motor scores were performed for each voxel.
RESULTS: RCPM score was significantly positively correlated with the FDOPA Ki in the left hippocampus and with the rrCMRglc in the left middle frontal gyrus and right retrosplenial cortex. Motor function was significantly positively correlated with the FDOPA Ki in the bilateral striatum and with the rrCMRglc in association areas and primary visual cortex. The level of motor function was significantly inversely correlated with the FDOPA Ki in the anterior cingulate gyrus and with the rrCMRglc in bilateral primary motor cortex and right putamen.
CONCLUSIONS: Changes of striatal FDOPA uptake and rrCMRglc in the primary motor cortex likely represent dysfunction in the motor system involving the corticobasal ganglia-thalamocortical loop. Change of FDOPA uptake in the anterior cingulate gyrus may be related to up-regulation of dopamine synthesis in surviving dopamine neurons. The regions where correlation with cognitive function was observed belong to a cognitive frontoparietal-hippocampal network.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15193583     DOI: 10.1016/j.neuroimage.2004.01.030

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  27 in total

Review 1.  Gender differences in Parkinson's disease: clinical characteristics and cognition.

Authors:  Ivy N Miller; Alice Cronin-Golomb
Journal:  Mov Disord       Date:  2010-12-15       Impact factor: 10.338

Review 2.  PET/CT in diagnosis of movement disorders.

Authors:  Valentina Berti; Alberto Pupi; Lisa Mosconi
Journal:  Ann N Y Acad Sci       Date:  2011-06       Impact factor: 5.691

Review 3.  Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease.

Authors:  Yunqi Xu; Junqiang Yan; Peng Zhou; Jiejie Li; Huimin Gao; Ying Xia; Qing Wang
Journal:  Prog Neurobiol       Date:  2012-02-25       Impact factor: 11.685

4.  Brain (18)F-DOPA PET and cognition in de novo Parkinson's disease.

Authors:  Agnese Picco; Silvia Morbelli; Arnoldo Piccardo; Dario Arnaldi; Nicola Girtler; Andrea Brugnolo; Irene Bossert; Lucio Marinelli; Antonio Castaldi; Fabrizio De Carli; Claudio Campus; Giovanni Abbruzzese; Flavio Nobili
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-03-28       Impact factor: 9.236

Review 5.  Fibrofog and fibromyalgia: a narrative review and implications for clinical practice.

Authors:  Howard M Kravitz; Robert S Katz
Journal:  Rheumatol Int       Date:  2015-01-13       Impact factor: 2.631

Review 6.  Cognitive impairment and dementia in basal ganglia disorders.

Authors:  Julie C Stout; Shannon A Johnson
Journal:  Curr Neurol Neurosci Rep       Date:  2005-09       Impact factor: 5.081

7.  Characterizing dementia with Lewy bodies by means of diffusion tensor imaging.

Authors:  Rosie Watson; Andrew M Blamire; Sean J Colloby; Josh S Wood; Robert Barber; Jiabao He; John T O'Brien
Journal:  Neurology       Date:  2012-08-15       Impact factor: 9.910

8.  Regional CBF changes in Parkinson's disease: a correlation with motor dysfunction.

Authors:  Jung-Lung Hsu; Tzyy-Ping Jung; Chien-Yeh Hsu; Wei-Chih Hsu; Yen-Kung Chen; Jeng-Ren Duann; Han-Cheng Wang; Scott Makeig
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-04-17       Impact factor: 9.236

9.  'Prefrontal' cognitive performance of healthy subjects positively correlates with cerebral FDOPA influx: an exploratory [18F]-fluoro-L-DOPA-PET investigation.

Authors:  Ingo Vernaleken; Hans-Georg Buchholz; Yoshitaka Kumakura; Thomas Siessmeier; Peter Stoeter; Peter Bartenstein; Paul Cumming; Gerhard Gründer
Journal:  Hum Brain Mapp       Date:  2007-10       Impact factor: 5.038

10.  Chronic therapy with citalopram decreases regional cerebral glucose utilization in OBX, and not sham-operated, rats: an autoradiographic study.

Authors:  Ivan Skelin; Hiroki Sato; Tomislav Kovacević; Mirko Diksic
Journal:  Psychopharmacology (Berl)       Date:  2009-09-17       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.